Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Brian Haylock"'
Autor:
Elisabeth J. Shaw, Brian Haylock, David Husband, Daniel du Plessis, D. Ross Sibson, Peter C. Warnke, Carol Walker
Publikováno v:
Analytical Cellular Pathology, Vol 33, Iss 2, Pp 81-94 (2010)
Background: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivit
Externí odkaz:
https://doaj.org/article/3956c6b428aa4d5796083b26cd4cde45
Autor:
Brian Haylock, Bridget Young, Priya Francis, Frances C Sherratt, Carrol Gamble, Helen Hickey, Michael D. Jenkinson, Stephen L. Brown
Publikováno v:
The Oncologist
ONCOLOGIST
ONCOLOGIST
Introduction Providing balanced information that emphasizes clinical equipoise (i.e., uncertainty regarding the relative merits of trial interventions) and exploring patient treatment preferences can improve informed consent and trial recruitment. Wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4add6c298c0528eaee1a5541b328b34
https://doi.org/10.1634/theoncologist.2019-0571
https://doi.org/10.1634/theoncologist.2019-0571
Autor:
Michael D. Jenkinson, Brian Haylock, Midhun Mohan, Abdurrahman I. Islim, Richard D C Moon, Anna Crofton, Nitika Rathi, Andrew Brodbelt, Samantha J Mills, Ruwanthi Kolamunnage-Dona
Publikováno v:
WORLD NEUROSURGERY
Background Incidental findings such as meningioma are becoming increasingly prevalent. There is no consensus on the optimal management of these patients. The aim of this study was to examine the outcomes of patients diagnosed with an incidental menin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04042942128aebc2e007e546d890b99
http://livrepository.liverpool.ac.uk/3080559/1/1-s2.0-S1878875020305295-main.pdf
http://livrepository.liverpool.ac.uk/3080559/1/1-s2.0-S1878875020305295-main.pdf
Clinical studies of incidental intracranial meningiomas—towards high-quality evidence-based practice
Autor:
Brian Haylock, Michael D. Jenkinson, Samantha J Mills, Ryan K. Mathew, Kirsty J Martin-McGill, Andrew Brodbelt, Abdurrahman I. Islim, Christopher P. Millward, Ruwanthi Kolamunnage-Dona, Thomas Santarius
Publikováno v:
Acta Neurochirurgica. 162:673-674
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d822e10f1dd77e9ffd02d7d1dced2b20
https://doi.org/10.1007/s00701-020-04214-y
https://doi.org/10.1007/s00701-020-04214-y
Autor:
Abdurrahman Islim, David Husband, Aditya Shenoy, Jeffrey Smith, Siddhant Kumar, Samantha J Mills, Emmanuel Chavredakis, Andrew Brodbelt, Michael D. Jenkinson, David Lawson, Brian Haylock
Publikováno v:
Neuro Oncol
BACKGROUND Primary CNS lymphoma (PCNSL) requires a biopsy for diagnosis. Administration of corticosteroids can lead to inconclusive results and delay diagnosis. The aim of this study was to compare outcomes of patients treated under haematology compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e135924ee3fa0220224db4d0f0ea69ed
https://europepmc.org/articles/PMC6847497/
https://europepmc.org/articles/PMC6847497/
Autor:
Brian Haylock, Nitika Rathi, Richard D C Moon, Midhun Mohan, Ruwanthi Kolamunnage-Dona, Andrew Brodbelt, Anna Crofton, Samantha J Mills, Michael D. Jenkinson, Abdurrahman I. Islim
Publikováno v:
Neuro Oncol
Neuro-Oncology
Neuro-Oncology
Background Asymptomatic meningioma is a common incidental finding with no consensus on the optimal management strategy. We aimed to develop a prognostic model to guide personalized monitoring of incidental meningioma patients. Methods A prognostic mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50bc4534d484160f725e279e8cb68b26
https://pubmed.ncbi.nlm.nih.gov/31875227
https://pubmed.ncbi.nlm.nih.gov/31875227
Autor:
Andrew Brodbelt, Jeffery Smith, Grace Chapman, Michael D. Jenkinson, David Lawson, Adam Ridzuan-Allen, Brian Haylock, Emmanuel Chavredakis, Tamara Ali, Nawani Wickramaratne, Samantha J Mills, Aditya Shenoy, Imogen Harrison, David Husband, Siddhant Kumar, Abdurrahman I. Islim
Publikováno v:
Neuro Oncol
Introduction Primary CNS lymphoma (PCNSL) requires a biopsy for diagnosis but can be inconclusive when steroids are administered. Without treatment median survival is 1.5–3.3 months, improving to 10–20 months with oncological treatment. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a609d1703628baf86b0937be2e119a
https://doi.org/10.1093/neuonc/noz167.017
https://doi.org/10.1093/neuonc/noz167.017
Autor:
Brian Haylock, Michael Brada
Publikováno v:
American Society of Clinical Oncology Educational Book. :e89-e94
Radiotherapy (RT) remains the principal component of glioma treatment, and three-dimensional conformal RT (3DCRT) is the current standard of RT delivery. Advances in imaging and in RT technology have enabled more precise treatment to defined targets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96e1bd1e237688edf26567d1a07b66bd
https://doi.org/10.14694/edbook_am.2014.34.e89
https://doi.org/10.14694/edbook_am.2014.34.e89
Autor:
Brian Haylock, Rdc Moon, Nitika Rathi, Ruwanthi Kolamunnage-Dona, Jenkinson, Abdurrahman I. Islim, Midhun Mohan, Andrew Brodbelt, Samantha J Mills
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 90:e9.3-e10
ObjectivesDevelop a model to identify incidental meningiomas at risk of observation failure.DesignRetrospective study (2007–2015).Subjects385 patients. Mean age 62.6 years.MethodsObservation failure was defined as: new symptoms, MRI progression (ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b7a49c2face86c5a48a887260bbfcd5
https://doi.org/10.1136/jnnp-2019-abn.29
https://doi.org/10.1136/jnnp-2019-abn.29
Autor:
Michael D. Jenkinson, Rasheed Zakaria, Brian Haylock, Atik Baborie, Helen Wong, Christopher P. Millward, Aditya Shenoy, Andrew Brodbelt, Daniel Crooks, David Husband
Publikováno v:
ACTA NEUROCHIRURGICA
Increasingly, biomarkers have been identified that correlate with improved overall and progression-free survival (OS and PFS) in glioblastoma, including MGMT methylation status and mutations in the IDH1 gene. In this study, we investigated the clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e88252a0d2818003cb3df517602b4e